Insider Transactions in Q3 2025 at Idexx Laboratories Inc (IDXX)
Insider Transaction List (Q3 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 01
2025
|
Martin Alexander Smith Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
5
-0.35%
|
$3,235
$647.09 P/Share
|
Sep 01
2025
|
Martin Alexander Smith Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
18
+1.24%
|
-
|
Aug 22
2025
|
M Anne Szostak Director |
BUY
Bona fide gift
|
Indirect |
259
+50.0%
|
-
|
Aug 22
2025
|
M Anne Szostak Director |
SELL
Bona fide gift
|
Indirect |
259
-14.38%
|
-
|
Aug 22
2025
|
M Anne Szostak Director |
SELL
Open market or private sale
|
Direct |
2,187
-89.3%
|
$1,414,989
$647.33 P/Share
|
Aug 22
2025
|
M Anne Szostak Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,187
+47.17%
|
$450,522
$206.62 P/Share
|
Aug 15
2025
|
Jonathan Jay Mazelsky President and CEO |
SELL
Bona fide gift
|
Direct |
1,051
-1.26%
|
-
|
Aug 12
2025
|
Michael G Erickson Executive Vice President |
SELL
Open market or private sale
|
Direct |
405
-1.74%
|
$262,845
$649.92 P/Share
|
Aug 12
2025
|
Nimrata Hunt Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
1,226
+2.25%
|
$378,834
$309.76 P/Share
|
Aug 12
2025
|
Sharon E. Underberg EVP, GC & Corporate Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
183
+2.81%
|
$99,552
$544.08 P/Share
|
Aug 11
2025
|
Nimrata Hunt Executive Vice President |
SELL
Open market or private sale
|
Direct |
1,200
-6.66%
|
$787,200
$656.53 P/Share
|
Aug 08
2025
|
Jonathan Jay Mazelsky President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
183
+0.22%
|
$109,434
$598.49 P/Share
|
Aug 08
2025
|
Sharon E. Underberg EVP, GC & Corporate Secretary |
SELL
Open market or private sale
|
Direct |
5,450
-46.96%
|
$3,547,950
$651.6 P/Share
|
Aug 08
2025
|
Sharon E. Underberg EVP, GC & Corporate Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
5,450
+31.96%
|
$1,122,700
$206.94 P/Share
|
Aug 07
2025
|
Andrew Emerson EVP, CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
402
-9.41%
|
$261,300
$650.06 P/Share
|
Aug 07
2025
|
Andrew Emerson EVP, CFO and Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,849
+30.21%
|
$260,709
$141.6 P/Share
|
Aug 06
2025
|
Nimrata Hunt Executive Vice President |
SELL
Open market or private sale
|
Direct |
7,143
-10.49%
|
$4,500,090
$630.49 P/Share
|
Aug 06
2025
|
Nimrata Hunt Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
12,794
+16.64%
|
$2,238,950
$175.6 P/Share
|
Aug 06
2025
|
Michael Lane Executive Vice President |
SELL
Open market or private sale
|
Direct |
8,411
-21.76%
|
$5,282,108
$628.15 P/Share
|
Aug 06
2025
|
Michael Lane Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
8,411
+22.34%
|
$2,077,517
$247.86 P/Share
|
Aug 06
2025
|
Jonathan Jay Mazelsky President and CEO |
SELL
Open market or private sale
|
Direct |
29,260
-2.94%
|
$18,492,320
$632.72 P/Share
|
Aug 06
2025
|
Jonathan Jay Mazelsky President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
29,260
+20.63%
|
$1,960,420
$67.85 P/Share
|